Insulin aspart, recombinant Subcutaneous and Lanthanum Carbonate Tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Lanthanum Carbonate Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: lanthanum carbonate
Brand name: Fosrenol
Synonyms: Lanthanum carbonate, Lanthanum
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Lanthanum Chewable Tablets
- Insulin aspart, recombinant Subcutaneous-Lanthanum Powder
- Insulin aspart, recombinant Subcutaneous-Lantus
- Insulin aspart, recombinant Subcutaneous-Lantus SoloStar
- Insulin aspart, recombinant Subcutaneous-Lantus SoloStar (Insulin Glargine (U-100) Cartridge Systems and Pens)
- Insulin aspart, recombinant Subcutaneous-Lantus Solostar (Insulin Glargine (U-300) Pens)
- Lanthanum Carbonate Tablets-Insulin degludec
- Lanthanum Carbonate Tablets-Insulin Degludec (U-100) Prefilled Pens
- Lanthanum Carbonate Tablets-Insulin Degludec (U-100) Vials
- Lanthanum Carbonate Tablets-Insulin Degludec (U-200) Prefilled Pens
- Lanthanum Carbonate Tablets-Insulin degludec and liraglutide
- Lanthanum Carbonate Tablets-Insulin degludec and liraglutide Subcutaneous